Publications by authors named "Sheeba Thomas"

Claim this Profile
L
Long-term outcomes and treatment patterns in Waldenström macroglobulinemia patients who discontinue Bruton tyrosine kinase inhibitor (BTKi) therapy.
Karan L Chohan, Lorenzo Gensini, Sherif Seif, Xiaowen Sun, Lei Feng, Sheeba K Thomas

Blood Cancer J· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Results of delayed or salvage autologous hematopoietic stem cell transplantation for multiple myeloma.
Oren Pasvolsky, Curtis Marcoux, Denái R Milton, Asad A Haider, Mark R Tanner, Sheeba K Thomas

Bone Marrow Transplant· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Post-Transplant Outcomes in IgD Multiple Myeloma: A Propensity Score-Matched Analysis.
Curtis Marcoux, Denái R Milton, Mark R Tanner, Qaiser Bashir, Samer Srour, Sheeba K Thomas

Transplant Cell Ther· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of Patients With Multiple Myeloma With deletion 1p Following Autologous Stem Cell Transplant.
Curtis Marcoux, Denái R Milton, Mark R Tanner, Qaiser Bashir, Samer Srour, Sheeba K Thomas

Transplant Cell Ther· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of Multiple Myeloma Patients With Prior Solid Tumors Undergoing Autologous Transplantation.
Oren Pasvolsky, Curtis Marcoux, Denái R Milton, Natalie Rafaeli, Mark R Tanner, Sheeba K Thomas

Transplant Cell Ther· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal analysis of gut microbiome and metabolome correlates of response and toxicity with idecabtagene vicleucel.
Satabdi Saha, Lubna Rehman, Abdur Rehman, Faezeh Darbaniyan, Donna M Weber, Sheeba K Thomas

Blood Adv· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of patients with multiple myeloma undergoing autologous transplant with suboptimal pretransplant response.
Oren Pasvolsky, Muhammad Bilal Abid, Denái R Milton, Mark R Tanner, Qaiser Bashir, Sheeba K Thomas

Br J Haematol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Z
Zanubrutinib in Bing Neel syndrome: efficacy and tolerability.
Anne-Marie L Becking, Johannes P M van de Mortel, Oliver Tomkins, Thijs W H Flinsenberg, Nicole Japzon, Sheeba K Thomas

Leukemia· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I study of pomalidomide in relapsed or refractory Waldenström macroglobulinaemia.
Karan L Chohan, Donna M Weber, Lei Feng, L Michael Wang, Sattva S Neelapu, Sheeba K Thomas

Br J Haematol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcome of Patients With Central Nervous System Multiple Myeloma (CNS-MM) Treated With CNS-Directed Radiation Therapy.
Gohar S Manzar, Stephanie O Dudzinski, Alison K Yoder, Aaron Seo, Lewis F Nasr, Sheeba K Thomas

Clin Lymphoma Myeloma Leuk· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of Standard-Risk Multiple Myeloma Patients Who Undergo Upfront Autologous Hematopoietic Stem Cell Transplantation.
Oren Pasvolsky, Curtis Marcoux, Zhongya Wang, Denái R Milton, Babar Pal, Sheeba K Thomas

Transplant Cell Ther· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Direct-Acting Antivirals Induce Lymphoproliferative Disease Response in HCV-Infected Patients With Indolent B-Cell Non-Hodgkin's Lymphoma: A Prospective Observational Study.
Monica George, Khalis Mustafayev, Sairah Ahmed, Sheeba K Thomas, Ying Jiang

Hematol Oncol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of body mass index on outcomes of multiple myeloma patients undergoing upfront autologous stem cell transplant.
Curtis Marcoux, Sarah Pasyar, Denái R Milton, Hina N Khan, Mark R Tanner, Sheeba K Thomas

Br J Haematol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-cell analysis of neoplastic plasma cells identifies myeloma pathobiology mediators and potential targets.
Luz Yurany Moreno Rueda, Hua Wang, Keiko Akagi, Minghao Dang, Amishi Vora, Sheeba K Thomas

Cell Rep Med· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Outcomes of Upfront Autologous Hematopoietic Stem Cell Transplantation in Patients With Newly Diagnosed Multiple Myeloma With Deletion 17p.
Curtis Marcoux, Oren Pasvolsky, Denái R Milton, Mark R Tanner, Qaiser Bashir, Sheeba K Thomas

Transplant Cell Ther· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimal infused CD34 cell dose in multiple myeloma patients undergoing upfront autologous hematopoietic stem cell transplantation.
Oren Pasvolsky, Curtis Marcoux, Denái R Milton, Babar Pal, Mark R Tanner, Sheeba K Thomas

Blood Cancer J· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trends in Outcomes After Upfront Autologous Transplant for Multiple Myeloma Over Three Decades.
Oren Pasvolsky, Curtis Marcoux, Jianliang Dai, Denái R Milton, Mark R Tanner, Sheeba K Thomas

Transplant Cell Ther· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Personalized neoantigen vaccines as early intervention in untreated patients with lymphoplasmacytic lymphoma: a non-randomized phase 1 trial.
Szymon J Szymura, Lin Wang, Tiantian Zhang, Soung-Chul Cha, Joo Song, Sheeba K Thomas

Nat Commun· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management and Outcomes of Patients with Refractory Solitary Plasmacytoma after Treatment with Definitive Radiation Therapy.
Penny Fang, Chelsea C Pinnix, Susan Y Wu, Hans C Lee, Krina K Patel, Sheeba K Thomas

Int J Radiat Oncol Biol Phys· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of pretransplant minimal residual disease in patients with multiple myeloma and a very good partial response or better receiving autologous hematopoietic stem cell transplantation.
Oren Pasvolsky, Sarah Pasyar, Roland L Bassett, Hina N Khan, Mark R Tanner, Sheeba K Thomas

Cancer· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of revised International Staging System 2 risk stratification on outcomes of patients with multiple myeloma receiving autologous haematopoietic stem cell transplantation.
Kamal Alzahrani, Oren Pasvolsky, Zhongya Wang, Denái R Milton, Mark R Tanner, Sheeba K Thomas

Br J Haematol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiple myeloma patients with a long remission after autologous hematopoietic stem cell transplantation.
Oren Pasvolsky, Zhongya Wang, Denái R Milton, Mark R Tanner, Qaiser Bashir, Sheeba K Thomas

Blood Cancer J· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elevated pro-inflammatory cytokines and chemokines in saliva of cats with feline odontoclastic resorptive lesion.
Sheeba Thomas, David Francis Lappin, David Bennett, Christopher Nile, Marcello Pasquale Riggio

Res Vet Sci· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of patients with multiple myeloma and 1q gain/amplification receiving autologous hematopoietic stem cell transplant: the MD Anderson cancer center experience.
Oren Pasvolsky, Sassine Ghanem, Denái R Milton, Mikael Rauf, Mark R Tanner, Sheeba K Thomas

Blood Cancer J· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-in-human clinical trial of personalized neoantigen vaccines as early intervention in untreated patients with lymphoplasmacytic lymphoma.
Larry Kwak, Szymon Szymura, Lin Wang, Tiantian Zhang, Soung-Chul Cha, Sheeba Thomas

Res Sq· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis